Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,480.00
-150.00 (-2.26%)
At close: Mar 19, 2026
Market Cap57.37B -4.5%
Revenue (ttm)77.09B -6.5%
Net Income731.98M
EPS55.00
Shares Out8.83M
PE Ratio118.18
Forward PEn/a
Dividend95.47 (1.47%)
Ex-Dividend DateDec 29, 2025
Volume47,644
Average Volume91,195
Open6,630.00
Previous Close6,630.00
Day's Range6,190.00 - 6,660.00
52-Week Range5,800.00 - 9,226.11
Beta0.84
RSI52.19
Earnings DateMar 26, 2026

About Seoulin Bioscience

Seoulin Bioscience Co.,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company offers solutions for bio research and production; ecoTree, a SLB-120 instrument which produces slightly acidic electrolyzed water for used in food industry, living, and laboratory; plasma-based medical esthetics; miQ for the diagnosis of dementia; and functional cosmetics based on natural fermentation. Seoulin Bioscience Co.,Ltd. was founded in 1984 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1984
Employees 104
Stock Exchange KOSDAQ
Ticker Symbol 038070
Full Company Profile

Financial Performance

Financial Statements